IHT Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45M Sell
34,511
-6,131
-15% -$195K 0.03% 494
2026
Q1
$1.07M Buy
40,642
+15,557
+62% +$456K 0.03% 546
2025
Q4
$727K Sell
25,085
-10,699
-30% -$321K 0.02% 637
2025
Q3
$994K Buy
35,784
+6,415
+22% +$162K 0.03% 532
2025
Q2
$715K Sell
29,369
-1,123
-4% -$24.6K 0.02% 594
2025
Q1
$633K Buy
30,492
+5,985
+24% +$150K 0.02% 600
2024
Q4
$577K Buy
24,507
+16,563
+208% +$408K 0.02% 635
2024
Q3
$203K Buy
+7,944
New +$202K 0.01% 1085
2021
Q4
Sell
-6,685
Closed -$499K 809
2021
Q3
$499K Sell
6,685
-1,911
-22% -$160K 0.04% 431
2021
Q2
$795K Buy
8,596
+28
+0.3% +$2.38K 0.05% 384
2021
Q1
$760K Buy
8,568
+2,950
+53% +$293K 0.05% 337
2020
Q4
$524K Buy
+5,618
New +$448K 0.04% 392

Other funds holding ARKG

IHT Wealth Management's ARKG Position: Q2 2026 in Review

IHT Wealth Management reduced its ARK Genomic Revolution ETF (ARKG) stake by 15% in Q2 2026, selling an estimated $195K and leaving 34,511 shares worth $1.45M. The position accounts for 0.03% of the portfolio, ranked #494.

IHT Wealth Management first reported a position in ARKG in Q4 2020 and has held it in 12 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • IHT Wealth Management held 34,511 shares of ARK Genomic Revolution ETF worth $1.45M as of Q2 2026.
  • IHT Wealth Management sold 6,131 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $195K.
  • ARK Genomic Revolution ETF made up 0.03% of IHT Wealth Management's portfolio in Q2 2026, its #494 holding.
  • IHT Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 12 quarters since.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on IHT Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.